Immunology & Autoimmune
Part of Biotech - Drug Development
| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
 JNJ | Johnson & Johnson | $0.6t | $225.21 | -1.0% | 7.9M |
 ABBV | ABBVIE INC. | $377.0b | $198.28 | -0.2% | 7.5M |
 AMGN | Amgen Inc | $188.1b | $340.17 | -1.3% | 2.6M |
 BMY | Bristol-Myers Squibb Co. | $122.0b | $57.89 | -1.4% | 10.7M |
 REGN | Regeneron Pharmaceuticals Inc | $79.2b | $744.61 | -0.9% | 603.2K |
 ROIV | Roivant Sciences Ltd. Common Shares | $18.9b | $27.85 | +1.6% | 5.0M |
 IBRX | ImmunityBio, Inc. Common Stock | $6.8b | $7.30 | -1.9% | 11.1M |
 PTGX | Protagonist Therapeutics, Inc | $6.4b | $98.43 | -1.6% | 994.7K |
 APGE | Apogee Therapeutics, Inc. Common Stock | $5.9b | $86.53 | +1.1% | 970.5K |
 TGTX | TG Therapeutics, Inc. | $5.0b | $35.38 | -3.4% | 1.7M |
 IMVT | Immunovant, Inc. Common Stock | $4.8b | $28.63 | +0.2% | 934.9K |
 DNTH | Dianthus Therapeutics, Inc. Common Stock | $4.2b | $87.14 | -0.3% | 599.3K |
 SYRE | Spyre Therapeutics, Inc. Common Stock | $3.6b | $71.86 | +3.1% | 686.9K |
 VERA | Vera Therapeutics, Inc. Class A Common Stock | $2.7b | $37.26 | -1.1% | 756.3K |
 ARQT | Arcutis Biotherapeutics, Inc. Common Stock | $2.6b | $23.43 | +0.7% | 821.6K |
 RCUS | Arcus Biosciences, Inc. | $2.6b | $24.95 | -2.2% | 1.1M |
 ALMS | Alumis Inc. Common Stock | $2.6b | $24.77 | -0.7% | 1.1M |
 ORKA | Oruka Therapeutics, Inc. Common Stock | $2.3b | $76.35 | +10.6% | 6.9M |
 APLS | Apellis Pharmaceuticals, Inc. Common Stock | $2.2b | $40.95 | +0.0% | 2.7M |
 ADMA | ADMA Biologics, Inc. | $2.2b | $10.93 | -2.9% | 5.6M |
 CLDX | Celldex Therapeutics, Inc | $2.0b | $33.66 | +1.1% | 851.7K |
 ANAB | AnaptysBio, Inc. Common Stock | $1.9b | $66.60 | +13.1% | 1.1M |
 NKTR | Nektar Therapeutics | $1.9b | $86.78 | -5.4% | 1.6M |
 AUPH | Aurinia Pharmaceuticals Inc | $1.9b | $16.38 | +2.5% | 1.1M |
 BHVN | Biohaven Ltd. | $1.2b | $9.59 | -2.9% | 1.4M |
 MLTX | MoonLake Immunotherapeutics Class A Ordinary Shares | $1.2b | $16.85 | -1.9% | 480.1K |
 CRVS | Corvus Pharmaceuticals, Inc. | $1.1b | $15.92 | -1.0% | 938.5K |
 DBVT | DBV Technologies S.A. | $1.1b | $20.39 | +3.0% | 159.9K |
 SEPN | Septerna, Inc. Common Stock | $1.0b | $25.07 | +1.6% | 370.8K |
 ZBIO | Zenas BioPharma, Inc. Common Stock | $1.0b | $18.60 | +2.3% | 344.5K |
 XNCR | Xencor, Inc. | $0.8b | $13.11 | +1.0% | 1.1M |
 CGEM | Cullinan Therapeutics, Inc. Common Stock | $0.8b | $13.25 | +0.2% | 600.1K |
 EVMN | Evommune, Inc. | $0.8b | $25.06 | -1.3% | 218.3K |
 ANNX | Annexon, Inc. Common Stock | $0.7b | $6.13 | +4.2% | 3.1M |
 JBIO | Jade Biosciences, Inc. Common Stock | $0.7b | $26.83 | +7.4% | 915.8K |
 ZURA | Zura Bio Limited Class A Ordinary Shares | $0.5b | $5.41 | +0.5% | 538.5K |
 UPB | Upstream Bio, Inc. Common Stock | $477.8m | $9.29 | -0.1% | 664.7K |
 RIGL | Rigel Pharmaceuticals Inc. (New) | $475.1m | $30.48 | +0.6% | 200.3K |
 KYTX | Kyverna Therapeutics, Inc. Common Stock | $458.3m | $8.98 | -0.9% | 1.1M |
 IMMX | Immix Biopharma, Inc. Common Stock | $454.4m | $9.51 | -3.5% | 462.2K |
 STTK | Shattuck Labs, Inc. Common Stock | $426.5m | $7.74 | 0.0% | 421.6K |
 ACRS | Aclaris Therapeutics, Inc. | $422.6m | $4.41 | +2.6% | 814.1K |
 IPSC | Century Therapeutics, Inc. Common Stock | $364.8m | $2.23 | +0.7% | 568.6K |
 ENTA | Enanta Pharmaceuticals, Inc | $353.5m | $13.31 | 0.0% | 92.4K |
 FBRX | Forte Biosciences, Inc. Common Stock | $329.7m | $26.74 | -2.6% | 182.6K |
 AVTX | Avalo Therapeutics, Inc. Common Stock | $317.4m | $14.48 | +4.1% | 680.0K |
 CLYM | Climb Bio, Inc. Common Stock | $312.4m | $9.51 | +4.0% | 433.7K |
 PALI | Palisade Bio, Inc. Common Stock | $295.6m | $1.94 | -6.7% | 3.4M |
 CABA | Cabaletta Bio, Inc. Common Stock | $275.0m | $2.92 | -0.8% | 1.2M |
 SABS | SAB Biotherapeutics, Inc. Common Stock | $265.6m | $3.47 | -1.4% | 423.9K |